In the past two decades, scientists and government agencies have developed methods to identify carcinogenic chemicals, explore cancer mechanisms, and quantify the risks from exposures. There is an increasing lack of consensus among scientists on the application of risk assessment to prevent cancer in humans based on animal bioassays. The United States and European government agencies use substantially different approaches in assessing cancer risks. A relatively small number of chemicals have been identified to be human carcinogens; a large number of chemicals have been proposed to be potential carcinogens in humans based on animal studies. A challenge for scientists is to assess the risks of chemicals accurately in order to provide adequate protection of public health, yet not prevent technological development. The American Health Foundation (AHF) proposes to convene an International Expert Panel comprised of 15 prestigious scientists to address the following issues: Species to Species Extrapolation: The panel will examine the data correlating human cancer and animal tumors. Animal tumor types resulting from stimulation by proliferative agents such as promoters and hormones will be analyzed for their significance to human cancer. Threshold Doses: The Panel will analyze dose-response relations exhibiting thresholds for epigenetic and genetic carcinogens. The Panel will meet twice during 1990. Support is requested for the development of a scientific publication reviewing the literature and reporting the consensus of the Panel to be published in a peer-reviewed journal. The support for meeting expenses will come from AHF funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Conference (R13)
Project #
1R13CA053160-01
Application #
3434144
Study Section
Special Emphasis Panel (SRC (Z2))
Project Start
1991-03-01
Project End
1992-02-29
Budget Start
1991-03-01
Budget End
1992-02-29
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Whysner, J; Williams, G M (1996) 2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:193-223
Verna, L; Whysner, J; Williams, G M (1996) N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71:57-81
Whysner, J; Conaway, C C; Verna, L et al. (1996) Vinyl chloride mechanistic data and risk assessment: DNA reactivity and cross-species quantitative risk extrapolation. Pharmacol Ther 71:7-28
Verna, L; Whysner, J; Williams, G M (1996) 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. Pharmacol Ther 71:83-105
Whysner, J; Williams, G M (1996) d-limonene mechanistic data and risk assessment: absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:127-36
Whysner, J; Verna, L; Williams, G M (1996) Benzidine mechanistic data and risk assessment: species- and organ-specific metabolic activation. Pharmacol Ther 71:107-26
Whysner, J; Williams, G M (1996) Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:137-51
(1996) The use of mechanistic data in the risk assessments of ten chemicals: an introduction to the chemical-specific reviews. International Expert Panel on Carcinogen Risk Assessment. Pharmacol Ther 71:1-5
Conaway, C C; Whysner, J; Verna, L K et al. (1996) Formaldehyde mechanistic data and risk assessment: endogenous protection from DNA adduct formation. Pharmacol Ther 71:29-55
Whysner, J; Ross, P M; Williams, G M (1996) Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:153-91